泰尔米沙坦改善高血压诱导的损伤通过恢复淋巴细胞内皮屏障功能
1Department of Blood Purification Center, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
Journal of biochemical and molecular toxicology
|July 4, 2025
概括
泰尔米沙坦通过降低血压和炎症来保护脏免受高血压损伤. 它还可以改善功能,并恢复淋巴细胞中的关键蛋白质,提供治疗潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管研究研究心血管研究
- 分子生物学分子生物学
背景情况:
- 高血压会通过内皮功能障碍和增加膜透性导致脏损伤.
- 泰尔米沙坦 (TEL) 是一种 ангиотензин II (Ang II) 受体阻断剂 (ARB),具有抗氧化和抗炎作用.
- 在高血压引起的损伤中,TEL对膜透性的影响需要进一步研究.
研究的目的:
- 研究特尔米沙坦对高血压引起的脏损伤的保护作用.
- 探索TEL的机制,包括其对质透性的影响及其与克鲁佩尔样因子4 (KLF4) 的关联.
主要方法:
- 使用了一种对angiotensin II/高盐 (ANG/HS) 诱导的高血压的小鼠模型.
- 测量包括平均动脉压,纤维化,尿蛋白,血清肌,氧化应激标志物和炎症标志物 (IL-6,TNF-α).
- 紧结蛋白 zonula occludens-1 (ZO-1) 和 KLF4 的表达在脏组织和人类脏球膜内皮细胞 (HrGECs) 中被分析.
主要成果:
- 在高血压小鼠中,TEL治疗显著降低了平均动脉压,纤维化,尿蛋白和血清肌素.
- TEL抑制了氧化应激,并在组织中降低了IL-6和TNF-α的表达.
- 在KLF4.4的介导下,TEL恢复了质ZO-1表达和减少了内皮单层透性在体外.
结论:
- 泰尔米沙坦通过抗氧化和抗炎作用减轻高血压引起的损伤.
- 通过KLF4依赖机制,TEL通过降低淋巴细胞内皮透气性来保护功能.
- 泰尔米沙坦显示出作为治疗高血压相关损伤的治疗剂的潜力.
更多相关视频
08:21A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
5.0K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
665
相关概念视频
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
931
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
931
01:25Antihypertensive Drugs: Direct Renin Inhibitors
835
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
835
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
516
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
516
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
893
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
893
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
227
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
227
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
777
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
777